InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-46.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Solomon Jonathan Eitan, Chief Executive Officer. Officer active across 1 company, notably BiomX Inc.. Aggregated, 5 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €169k. History available since 28 July 2021. The latest transaction was disclosed on 14 April 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
126,748 shares0Common StockSEC:0001213900-25-033485:0
126,748 shares0Common StockSEC:0001213900-25-033352:0
50,556 shares0Common StockSEC:0001213900-24-079863:0
25,000 shares@ US$4.000.64% mcap50.0% of flowCommon StockSEC:0001213900-21-039437:0
Ideal exit: 24 Apr 2022 (T+270)
25,000 shares@ US$4.0050.0% of flowCommon StockSEC:0001213900-21-039437
Ideal exit: 24 Apr 2022 (T+270)
5 of 5 declarations
About Solomon Jonathan Eitan
Jonathan Eitan Solomon is the Chief Executive Officer at BiomX Inc. He is responsible for the overall direction of the company, overseeing operations and growth strategies. His role is essential for the success and performance of the business.
